In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest-Reference-Cited by-同舟云学术

In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

Published:2007-03 Issue:3 Volume:51 Page:1126-1129
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Torres-Narbona Marta¹,Guinea Jesús¹,Martínez-Alarcón José¹,Peláez Teresa¹,Bouza Emilio¹

Affiliation:

1. Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, University of Madrid, Spain

Abstract

ABSTRACT We evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posaconazole against zygomycetes by CLSI M38-A, Etest and Sensititre. The most active drug was posaconazole, followed by amphotericin B and itraconazole. The correlation of the Etest and Sensititre with CLSI M38-A was moderate for posaconazole but poor for the others.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01539-06

Reference32 articles.

1. Berenguer, J., P. Munoz, F. Parras, V. Fernandez-Baca, T. Hernandez-Sampelayo, and E. Bouza. 1994. Treatment of deep mycoses with liposomal amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis.13:504-507.

2. Bouza, E., P. Munoz, and J. Guinea. 2006. Mucormycosis: an emerging disease? Clin. Microbiol. Infect.12(Suppl. 7):7-23.

3. Brugiere, O., G. Dauriat, H. Mal, R. Marrash-Chalha, M. Fournier, O. Groussard, M. Besnard, G. Leseche, and B. Dupont. 2005. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation80:1361-1362.

4. Cagatay, A. A., S. S. Oncu, S. S. Calangu, T. T. Yildirmak, H. H. Ozsut, and H. H. Eraksoy. 2001. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect. Dis.1:22.

5. Reference deleted.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commercial Methods for Antifungal Susceptibility Testing of Saprophytic Molds: Can They Be Used to Detect Resistance?;Journal of Fungi;2024-03-14

2. Syncephalastrum massiliense sp. nov. and Syncephalastrum timoneanum sp. nov. Isolated from Clinical Samples;Journal of Fungi;2024-01-13

3. In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens;Brazilian Journal of Microbiology;2023-11-07

4. Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections;Journal of Fungi;2023-06-12

5. Amphotericin B, itraconazole, posaconazole, and isavuconazole MICs against clinical Mucorales isolates obtained by visual inspection and spectrophotometric reading according to the EUCAST 9.4 procedure;Medical Mycology;2023-04-27